These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13627772)

  • 1. Chemotherapy of cancer by ethylenimino quinones; its foundations and problems.
    DOMAGK G
    Ann N Y Acad Sci; 1958 Apr; 68(3):1197-204. PubMed ID: 13627772
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experiences with ethyleneimino-quinone (E 39) in chemotherapy of various neoplasms].
    DI PIETRO S
    Riforma Med; 1957 Jun; 71(22):608-14. PubMed ID: 13454502
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE EFFECTS OF 2,3,5-TRIS-ETHYLENIMINO-1,4-BENZOQUINONE ON OXYGEN-CONSUMING REACTIONS IN YOSHIDA ASCITES SARCOMA CELLS].
    HOELZEL F; MAASS H; BOCK H
    Arzneimittelforschung; 1964 Jul; 14():792-6. PubMed ID: 14344719
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro studies on the action of the cytostatic drug 2,5-bis-N-propyl-3,6-bis-ethylenimino-1,4-benzoquinone on bacteria].
    KREBS D
    Arzneimittelforschung; 1962 Jun; 12():588-90. PubMed ID: 14459502
    [No Abstract]   [Full Text] [Related]  

  • 5. [Attempted treatment of advanced cancer with a derivative of the ethylene-imine-quinone group (E 39 or 6870 RP)].
    JANBON M; BERTRAND L; BERTRAND A; FLANDRE O
    Montp Med; 1958 Jun; 53(6):863-4. PubMed ID: 13589947
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prolonged oral medication of Bayer E39 (cytostatic)].
    HESSE F; KAMPEN G
    Krebsarzt; 1957 Jun; 12(3):150-6. PubMed ID: 13450292
    [No Abstract]   [Full Text] [Related]  

  • 7. [Critical evaluation of certain results obtained with E-39].
    FARELLO G
    Riforma Med; 1957 Jun; 71(22):630-5. PubMed ID: 13454507
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of Bayer E 39 in otolaryngology; clinical and histological study].
    BAUER E
    Krebsarzt; 1957 Jun; 12(3):129-50. PubMed ID: 13450291
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fundamentals & problems of chemotherapy of tumors].
    DOMAGK G
    Riforma Med; 1957 Jun; 71(22):601-3. PubMed ID: 13454500
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical findings on 2, 5-dipropoxy-3, 6-bis-ethylenimino-p-benzoquinone].
    PEDERZINI A; SCARDOVI GA; REZZATTI I
    Prog Med (Napoli); 1959 Mar; 15(5):143-9. PubMed ID: 13667953
    [No Abstract]   [Full Text] [Related]  

  • 11. [E 39, a new antitumoral substance of the ethyleneimine-qulnone group; properties and clinical indications].
    PESTEL M
    Presse Med (1893); 1956 Sep; 64(64):1474-5. PubMed ID: 13379258
    [No Abstract]   [Full Text] [Related]  

  • 12. [Failure of attempted treatment of multiregional lymphosarcomatosis with the new antitumoral quinone E 39].
    MOULINIER J
    J Med Bord; 1957 Jul; 134(7):953-6. PubMed ID: 13449493
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary report on the treatment of plasmocytoma with an ethyleneimino-quinone preparation (E 39 Bayer)].
    HEILMANN D
    Dtsch Med J; 1957 Nov; 8(11):565-9. PubMed ID: 13490130
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary report on the use of a new cytotoxic drug in the treatment of tumors].
    ROSA L; GIUNGI F; FRANCO T
    Riforma Med; 1957 Jun; 71(22):619-20. PubMed ID: 13454504
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical observations on the use of the compound E 39 in anticellular chemotherapy].
    CONSOLI G; RUSSO N
    Riforma Med; 1957 Jun; 71(22):624-9. PubMed ID: 13454506
    [No Abstract]   [Full Text] [Related]  

  • 16. Local cytostatic chemotherapy and immunotherapy.
    Klein E
    Geriatrics; 1968 May; 23(5):154-75. PubMed ID: 4869008
    [No Abstract]   [Full Text] [Related]  

  • 17. [New antineoplastic drugs].
    DE SOCIO V
    Rass Int Clin Ter; 1957 Feb; 37(4):148-54. PubMed ID: 13420462
    [No Abstract]   [Full Text] [Related]  

  • 18. [Notes on the use of a new cytostatic drug in chemotherapy of tumors].
    MELAMPI M
    Boll Soc Ital Biol Sper; 1956 Dec; 32(12):1619-22. PubMed ID: 13446158
    [No Abstract]   [Full Text] [Related]  

  • 19. Are reduced quinones necessarily involved in the antitumour activity of quinone drugs?
    Butler J; Hoey BM
    Br J Cancer Suppl; 1987 Jun; 8():53-9. PubMed ID: 3307874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro comparative study with furyl-1,4-quinones endowed with anticancer activities.
    Benites J; Valderrama JA; Taper H; Buc Calderon P
    Invest New Drugs; 2011 Oct; 29(5):760-7. PubMed ID: 20237828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.